• Cloud DX has been selected as the Remote Patient Monitoring (RPM) platform for Hamilton Health Sciences (HHS) Surgical Transitions program
  • Launching this month, the program will monitor selected surgical patient populations using Cloud DX’s Connected Health platform
  • Patient outcome data will be included in research conducted by scientists at the Population Health Research Institute (PHRI) at McMaster University
  • Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care
  • Cloud DX (CDX) is up 27.78 per cent on the day, trading at C$0.23 per share at 1pm EST

Cloud DX (CDX) has been selected as the Remote Patient Monitoring (RPM) platform for Hamilton Health Sciences (HHS) Surgical Transitions program.

Robert Kaul, CEO of Cloud DX sat down with Caroline Egan to discuss the news.

“It is always an honour to be chosen by such innovative healthcare leaders as HHS and Medtronic. Building on research that proves conclusively how beneficial remote monitoring is for patient outcomes and care efficiency, HHS has now made Cloud DX Connected Health “standard of care” for many surgical patients, a giant step for virtual care in Canada. This contract will improve many people’s lives. It is also a signal to healthcare systems across Canada and the United States that virtual care is here to stay, and HHS Surgical Transitions is a shining example of a successful RPM implementation. For the company, this agreement represents a significant step toward our next milestone of enrolling 10,000 patients.”

Launching this month, the program will monitor selected surgical patient populations using Cloud DX’s Connected Health platform supported by HHS’s Virtual Nursing Station.

Additional kits will be purchased as needed to grow the program. Patient outcome data will be included in research conducted by scientists at the Population Health Research Institute (PHRI) at McMaster University to further prove the benefits and ROI of remote automated monitoring.

This contract comes after the company’s recent announcement of an exclusive virtual care partnership with Medtronic Canada.

Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care.

Cloud DX Inc. (CDX) is up 27.78 per cent on the day, trading at C$0.23 per share at 1pm EST.

More From The Market Online

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.